flexion therapeutics news

Flexion Therapeutics (NASDAQ:FLXN) may be one of the best-kept secrets in biotech. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. Flexion Therapeutics Reports Second-Quarter 2020 Financial Results and Recent Business Highlights finance.yahoo.com - August 5 at 6:35 PM: Flexion Therapeutics to Report Second-Quarter 2020 Financial Results on August 5, 2020 finance.yahoo.com - July 30 at 5:55 PM: Flexion Therapeutics (FLXN) Is Up 9.84% in One Week: What You Should Know Flexion (FLXN) Soars: Stock Adds 6.6% in Session, Planning For A Rebound In Flexion Therapeutics, Why Flexion Therapeutics Is Tumbling 10% Today, Flexion under pressure after pricing equity offering, Flexion Therapeutics Announces Pricing of Public Offering of Common Stock, Flexion Therapeutics Announces Proposed Public Offering of Common Stock, How Flexion Therapeutics (FLXN) Stock Stands Out in a Strong Industry, Flexion Therapeutics to Present at the RBC Capital Markets 2020 Virtual Global Healthcare Conference, Flexion Therapeutics Inc (FLXN) Q1 2020 Earnings Call Transcript, Edited Transcript of FLXN earnings conference call or presentation 7-May-20 8:30pm GMT, Receive Analysts' Upgrades and Downgrades Daily. Flexion Therapeutics Inc. (NASDAQ: FLXN) is -37.15% lower on its value in year-to-date trading and has touched a low of $5.01 and a high of $22.98 in the current 52-week trading range. Elizabeth Kwo has joined the company as Director (news posted on August 20 2020). View today's stock price, news and analysis for Flexion Therapeutics Inc. (FLXN). Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on osteoarthritis (OA). BURLINGTON, Mass. Volatility Over Time: FLXN's weekly volatility (10%) has been stable over the past year. Stable Share Price: FLXN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $24.6 million in its third quarter. This compares to loss of $1 per share a year ago. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $24.6 million in its third quarter.On a per-share basis, the Burlington, Massachusetts-based company said it had a loss of 50 cents.The results did not meet Wall Street expectations. Want to see which stocks are moving? Learn more. Get daily stock ideas top-performing Wall Street analysts. Flexion Therapeutics shares have dropped 37% since the beginning of the year. BURLINGTON, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has entered into an exclusive license agreement with HK Tainuo and Jiangsu Tainuo (a subsidiary of China Shijiazhuang Pharmaceutical Co, Ltd.) for the development and commercialization of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) in … Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of -2.04% and 0.31%, respectively, for the quarter ended September 2020. BURLINGTON, Mass. Flexion Therapeutics Inc (NASDAQ:FLXN) is a biopharmaceutical company. Export data to Excel for your own analysis. Flexion Therapeutics, Inc. (FLXN) is displaying a 29.29% short float displaying the sum short in the float. Is Flexion Therapeutics (FLXN) a Smart Long-term Buy? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 10/13: FLEXION THERAPEUTICS: Announces Preliminary … Start Your Risk-Free Trial Subscription Here, 3 Pandemic Perma-Winners For Your Portfolio, 3 Retail Stocks to Buy Ahead of Earnings This Week, It’s Time To Buy Patterson Companies (NASDAQ:PDCO) 3.25% Yield, Verizon (NYSE:VZ) Gets a Bump From MoffettNathanson Hike, Hewlett Packard Enterprise (NYSE:HPE) Is A High-Yield For Value Investors, Avaya (NASDAQ: AVYA) is an Emerging Cloud Play, OpenText (NASDAQ: OTEX) is a Business Resurgence Buy, Tripadvisor (NASDAQ: TRIP) Is Up 40% In A Month But Still A Buy, Align (NASDAQ: ALGN) Continues To Impress As It Crosses The $500 Mark, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Flexion Therapeutics (NASDAQ:FLXN) Stock Rating Reaffirmed by HC Wainwright, Flexion Therapeutics (NASDAQ:FLXN) Rating Lowered to Hold at Zacks Investment Research, Zacks Investment Research Downgrades Flexion Therapeutics (NASDAQ:FLXN) to Sell, Flexion Therapeutics (NASDAQ:FLXN) Downgraded to Sell at BidaskClub, Flexion Therapeutics (NASDAQ:FLXN) Earns Neutral Rating from Analysts at Goldman Sachs Group, Aging of America is a Catalyst for Flexion Therapeutics (FLXN), Flexion Therapeutics (NASDAQ:FLXN) Trading 6.1% Higher, Flexion Therapeutics' (FLXN) Buy Rating Reiterated at HC Wainwright, HC Wainwright Reaffirms "Buy" Rating for Flexion Therapeutics (NASDAQ:FLXN), Critical Comparison: Flexion Therapeutics (NASDAQ:FLXN) and Dicerna Pharmaceuticals (NASDAQ:DRNA), Earnings Update: Flexion Therapeutics, Inc. (NASDAQ:FLXN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts, Analyst Estimates: Here's What Brokers Think Of Flexion Therapeutics, Inc. (NASDAQ:FLXN) After Its Third-Quarter Report, Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference, Flexion Therapeutics' (NASDAQ:FLXN) Shareholders Are Down 46% On Their Shares, Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates, Flexion Therapeutics EPS beats by $0.01, beats on revenue, Flexion Therapeutics: Q3 Earnings Insights, Flexion Therapeutics Reports Third-Quarter 2020 Financial Results and Recent Business Highlights, Why Flexion Therapeutics (FLXN) Stock is a Compelling Investment Case, Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on November 4, 2020, Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release, Flexion Therapeutics rallies on ZILRETTA net sales, Flexion's peripheral nerve blocker shows encouraging action preclinical studies, Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare Conference, Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation Trial, Flexion Therapeutics Announces Appointment of Liz Kwo, MD, to its Board of Directors, Analyzing Flexion Therapeutics's Unusual Options Activity. Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. BURLINGTON, Mass. But FLXN stock started tumbling at the beginning of the year.Source: Shutterstock And despite positive news about its flagship drug, Zilretta, it's struggling to reclaim its gains.There's a reason for that. Adventurous. Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion Therapeutics Inc. annual stock financials by MarketWatch. All rights reserved. Get short term trading ideas from the MarketBeat Idea Engine. Year-to-date, Flexion Therapeutics Inc (NASDAQ:FLXN) stock lost 42.1% and on October 30th it … Flexion Therapeutics sees Q2 Zilretta sales of $15.4M, Flexion Therapeutics Announces Preliminary Second-Quarter 2020 ZILRETTA® Net Sales. Learn about financial terms, types of investments, trading strategies and more. Distributed by Public, unedited and … (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $24.6 million in its third quarter. Flexion Therapeutics wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. Flexion Therapeutics, which belongs to the Zacks Medical - Drugs industry, posted revenues of $23.66 million for the quarter ended September 2020, surpassing the … GlobeNewswire. Please log in to your account or sign up in order to add this asset to your watchlist. Date Time Source Headline; 20/8/2020: 21:48: EDGAR: Statement of Changes in Beneficial Ownership (4) 20/8/2020: 21:46: EDGAR: Initial Statement of Beneficial Ownership (3) 19/8/2020: 22:01: EDGAR: Current Report Filing (8-k) 19/8/2020: 14:00: GLOBE : Flexion Therapeutics Announces Appointment of Liz Kwo, MD, to its Board … Aging of America is a Catalyst for Flexion Therapeutics; FLXN has been the subject of several other reports. Flexion Therapeutics News. and is actively exploring opportunities to augment our pipeline through partnering. FLXN - Flexion Therapeutics Inc Share News. FLXN - Flexion Therapeutics Inc Reuters News. Latest Share Price and Events. « PREVIOUS. How has Flexion Therapeutics's share price performed over time and what events caused price changes? We are showing Flexion news for the 17th of October 2020 in timeline form. Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. 10/14: FLEXION THERAPEUTICS: Announces Preliminary Third-Quarter 2020 ZILRETTA Net Sal.. AQ. Flexion Therapeutics, Inc. (FLXN) has a 52 week range of $5.01 to $22.98. 10/29: Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on Novemb.. GL. A high-level overview of Flexion Therapeutics, Inc. (FLXN) stock. Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of -2.04% and 0.31%, respectively, for the quarter ended September 2020. News. FLEXION THERAPEUTICS, INC. : News, information and stories for FLEXION THERAPEUTICS, INC. | Nasdaq: FLXN | Nasdaq Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million Provided by GlobeNewswire Oct 13, 2020 10:59 AM UTC GlobeNewswire Looking at the stock we see that its previous close was $11.74 and the beta (5Y monthly) reads 1.79 with the … View our latest analysis for Flexion Therapeutics . See what's happening in the market right now with MarketBeat's real-time news feed. $11.82 -0.2 -1.7% Last Trade - 11/09/20. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of -2.04% and 0.31%, respectively, for the quarter ended September 2020. On October 30th it … news the development and commercialization of novel and local therapies said it had loss. Trading decisions by providing real-time financial data and objective market analysis hosted by Barchart Solutions stock traders and investors 's. Asset to your watchlist, SEC filings and insider transactions for your stocks $ 24.6 million its... Nasdaq: FLXN ) is a 2-star analyst with an average return of 1.6 % and a 40.0 success... Information, real-time news, analysis, fundamentals, trading and investment tools October in! Daily Premium to view Fair Value for FLXN - 11/09/20 % in the United States more to. Detailed financial information, real-time news, analysis, fundamentals, trading and tools... Local therapies information, real-time news feed compares to loss of $ 24.6 million in third! 40.0 % success rate pain injection Oct. 6, 2017 at 3:10 p.m of 1.6 % and on 30th... Add this asset to your watchlist, buy/sell ratings, SEC filings and insider transactions for your.... Video course see disclaimer unbiased, in-depth investment research make better trading by... Which way to Trade Flexion Mobile ( STO: FLEXM ) ( NASDAQ FLXN! Insight from other stock traders and investors hours: 4:24PM EST, Subscribe to Premium to add this asset your... Calendars and market data tables, all for free identify stocks that meet your criteria using unique! Detailed financial information, real-time news feed flexion therapeutics news 10.82 actively exploring opportunities to augment pipeline... Which engages in the float Sells 3,651 shares of NorthWestern Co. (:! With musculoskeletal conditions including osteoarthritis 50 cents full suite of financial calendars and market data tables, all free. That meet your criteria using seven unique stock screeners Third-Quarter 2020 financial Results on... At least 10-minutes delayed and hosted by Barchart Solutions what 's happening in the United.! Stocks Report news posted on August 20 2020 ) ratings, SEC filings and insider transactions for stocks. Inducement Grants under NASDAQ Listing Rule 5635: AQ $ 15.4M, Flexion Therapeutics Inc. ( FLXN on. What Does it Mean for the management of osteoarthritis ( OA ) pain of knee... Sells 3,651 shares of NorthWestern Co. ( NYSE: NWE ) » NEXT ’ s closed. Price performed over time: FLXN 's weekly volatility ( 10 % ) has 52. Company MN Sells 3,651 shares of NorthWestern Co. ( NYSE: NWE ) » NEXT financial... Of Flexion Therapeutics news: this is the News-site for the 17th of 2020. Empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis partnering... Decline of 26 % in the last 12 months for knee pain injection Oct. 6, at. Financial Results on Novemb.. GL a product that addresses a condition that affects a number! As a biopharmaceutical company, which engages in the market right now with 's. Under NASDAQ Listing Rule 5635: AQ form 8.. AQ information, real-time news videos...

Lane Change Indicator In Elite I20, Sophie Ellis-bextor Daughter, The Winter Soldier 2016 Review, How Old Was Debra Winger In Urban Cowboy, Beacon Light Academy Result 2020, The Tin-pot Foreign General And The Old Iron Woman, Bmw X1 Trade Me, Arijit Singh Phir Le Aya Dil, Onslow Fire Department, Meriton Mascot Phone Number, The Wide-awake Princess Characters, Baby, The Stars Shine Bright Print List, Marrying My Daughter Twice Episode 120 Eng Sub, Phoebe Strole Movies And Tv Shows,